Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2016 (2016), Article ID 3186051, 8 pages
http://dx.doi.org/10.1155/2016/3186051
Research Article

Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer

1The 2nd Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830000, China
2Department of Gynecology, Ninth Hospital of Xi’an, Xi’an, Shaanxi 715100, China

Received 7 December 2015; Revised 25 January 2016; Accepted 7 February 2016

Academic Editor: Emil Alexov

Copyright © 2016 Yun-Xia Zhang and Yan-Li Zhao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Stage, Cervical Cancer Treatment (PDQ®), National Cancer Institute, 2014.
  2. B. Terracini, “International Agency for Research on Cancer Monographs (IARC),” Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, vol. 30, pp. 83, 86–87, 2008. View at Google Scholar
  3. S. L. Parish, J. G. Swaine, E. Son, and K. Luken, “Determinants of cervical cancer screening among women with intellectual disabilities: evidence from medical records,” Public Health Reports, vol. 128, no. 6, pp. 519–526, 2013. View at Google Scholar · View at Scopus
  4. W. A. A. Tjalma, T. R. Van Waes, L. E. M. Van den Eeden, and J. J. P. M. Bogers, “Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 19, no. 4, pp. 469–483, 2005. View at Publisher · View at Google Scholar
  5. C. M. Martin, K. Astbury, L. McEvoy, S. O'Toole, O. Sheils, and J. J. O'Leary, “Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy,” in Inflammation and Cancer, S. V. Kozlov, Ed., vol. 511 of Methods in Molecular Biology™, pp. 333–359, Humana Press, New York, NY, USA, 2009. View at Publisher · View at Google Scholar
  6. F. Liu, D. Zhou, Q. Zhang, and B. Wang, “Comments on the article of Bu et al. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 3, pp. 3384–3385, 2015. View at Google Scholar
  7. H. Han, D. J. Bearss, L. W. Browne, R. Calaluce, R. B. Nagle, and D. D. Von Hoff, “Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray,” Cancer Research, vol. 62, no. 10, pp. 2890–2896, 2002. View at Google Scholar · View at Scopus
  8. A. H. O. Reis, F. R. Vargas, and B. Lemos, “More epigenetic hits than meets the eye: micrornas and genes associated with the tumorigenesis of retinoblastoma,” Frontiers in Genetics, vol. 3, article 284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Ganguly and C. L. Shields, “Differential gene expression profile of retinoblastoma compared to normal retina,” Molecular Vision, vol. 16, pp. 1292–1303, 2010. View at Google Scholar · View at Scopus
  10. X. Wu, R. Jiang, M. Q. Zhang, and S. Li, “Network-based global inference of human disease genes,” Molecular Systems Biology, vol. 4, no. 1, article 189, 2008. View at Publisher · View at Google Scholar
  11. J. Xu and Y. Li, “Discovering disease-genes by topological features in human protein-protein interaction network,” Bioinformatics, vol. 22, no. 22, pp. 2800–2805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liu, W.-H. Tang, X.-M. Zhao, and L. Chen, “A network approach to predict pathogenic genes for Fusarium graminearum,” PLoS ONE, vol. 5, Article ID e13021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-M. Zhao, Y. Wang, L. Chen, and K. Aihara, “Gene function prediction using labeled and unlabeled data,” BMC Bioinformatics, vol. 9, article 57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-M. Zhao, R.-S. Wang, L. Chen, and K. Aihara, “Uncovering signal transduction networks from high-throughput data by integer linear programming,” Nucleic Acids Research, vol. 36, article e48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Espinosa, A. Alfaro, E. Roman-Basaure et al., “Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer,” PLoS ONE, vol. 8, no. 2, Article ID e55975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Parmigiani, E. S. Garrett, R. A. Irizarry, and S. L. Zeger, The Analysis of Gene Expression Data: Methods and Software, Springer, New York, NY, USA, 2003. View at Publisher · View at Google Scholar
  17. A. Hamosh, A. F. Scott, J. S. Amberger, C. A. Bocchini, and V. A. McKusick, “Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders,” Nucleic Acids Research, vol. 33, pp. D514–D517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Mei, D. Zhou, J. Gao et al., “The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis,” BMC Cancer, vol. 12, article 467, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. G. R. Leisching, B. Loos, M. H. Botha, and A.-M. Engelbrecht, “The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer,” Toxicology, vol. 335, pp. 72–78, 2015. View at Publisher · View at Google Scholar
  20. Z. Jing, W. Heng, D. Aiping, Q. Yafei, and Z. Shulan, “Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer,” International Journal of Gynecological Cancer, vol. 23, no. 8, pp. 1465–1469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Ngernyuang, R. A. Francescone, P. Jearanaikoon et al., “Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer,” International Journal of Biochemistry and Cell Biology, vol. 51, no. 1, pp. 45–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. A. Stanczuk, E. N. Sibanda, C. Perrey et al., “Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production,” International Journal of Cancer, vol. 94, no. 6, pp. 792–794, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. D. Fritz and G. Radziwill, “CNK1 promotes invasion of cancer cells through NF-κB–dependent signaling,” Molecular Cancer Research, vol. 8, no. 3, pp. 395–406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-H. Kuo, C.-H. Chou, A.-L. Cheng, C.-W. Wang, Y.-H. Chen, and R.-J. Chen, “Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κBdependent cyclin D1 signaling,” Gynecologic Oncology, vol. 126, no. 2, pp. 245–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-S. Ryu, K.-H. Chang, H.-W. Yang, M.-S. Kim, H.-C. Kwon, and K.-S. Oh, “High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion,” Gynecologic Oncology, vol. 76, no. 3, pp. 320–325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Zehbe, M. Schmidt, M. Maeurer, C. Leo, M. Höckel, and H. Pilch, “Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions,” Zentralblatt fur Gynakologie, vol. 128, no. 5, pp. 266–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Li, C.-P. Yu, Y. Zhong et al., “Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer,” Annals of Oncology, vol. 23, no. 3, pp. 638–646, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Chen, L. Pirisi, and K. E. Creek, “Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer,” Virology, vol. 444, no. 1-2, pp. 100–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Polterauer, C. Grimm, C. Tempfer et al., “C-reactive protein is a prognostic parameter in patients with cervical cancer,” Gynecologic Oncology, vol. 107, no. 1, pp. 114–117, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Hölters, J. Anacker, L. Jansen, K. Beer-Grondke, M. Dürst, and I. Rubio, “Tetraspanin 1 promotes invasiveness of cervical cancer cells,” International Journal of Oncology, vol. 43, no. 2, pp. 503–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Lin, M. Bazzaro, M.-C. Wang, K. C. Chan, S. Peng, and R. B. S. Roden, “Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment,” Clinical Cancer Research, vol. 15, no. 2, pp. 570–577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, S. R. Reng, L. Wang et al., “Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy,” Medical Oncology, vol. 29, no. 3, pp. 1992–1997, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. E. Madsen, E. M. Ramos, M. Boulard et al., “Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer,” PLoS ONE, vol. 3, no. 6, Article ID e2492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Varughese, E. Cocco, S. Bellone et al., “Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody,” American Journal of Obstetrics and Gynecology, vol. 205, no. 6, pp. 567.e1–567.e7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. B. K. Prusty and B. C. Das, “Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin,” International Journal of Cancer, vol. 113, no. 6, pp. 951–960, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. Hassumi-Fukasawa, F. A. Miranda-Camargo, B. R. Zanetti, D. F. Galano, A. Ribeiro-Silva, and E. G. Soares, “Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV),” Pathology and Oncology Research, vol. 18, no. 4, pp. 929–937, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. R. E. Airley, J. Loncaster, J. A. Raleigh et al., “Glut-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding,” International Journal of Cancer, vol. 104, no. 1, pp. 85–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Rajkumar, K. Sabitha, N. Vijayalakshmi et al., “Identification and validation of genes involved in cervical tumourigenesis,” BMC Cancer, vol. 11, article 80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Smoot, K. Ono, J. Ruscheinski, P.-L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Kanehisa, M. Araki, S. Goto et al., “KEGG for linking genomes to life and the environment,” Nucleic Acids Research, vol. 36, no. 1, pp. D480–D484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Damiens, I. El Yazidi, J. Mazurier, I. Duthille, G. Spik, and Y. Boilly-Marer, “Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells,” Journal of Cellular Biochemistry, vol. 74, no. 3, pp. 486–498, 1999. View at Google Scholar · View at Scopus
  42. R. Visse and H. Nagase, “Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry,” Circulation Research, vol. 92, no. 8, pp. 827–839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. T. R. Cox and J. T. Erler, “Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer,” Disease Models and Mechanisms, vol. 4, no. 2, pp. 165–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. E. Hewitt, I. H. Leach, D. G. Powe, I. M. Clark, T. E. Cawston, and D. R. Turner, “Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours,” International Journal of Cancer, vol. 49, no. 5, pp. 666–672, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Nishioka, S. Sagae, A. Nishikawa, S.-I. Ishioka, and R. Kudo, “A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression,” Cancer Letters, vol. 200, no. 1, pp. 49–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. G. K. Schwartz and M. A. Shah, “Targeting the cell cycle: a new approach to cancer therapy,” Journal of Clinical Oncology, vol. 23, no. 36, pp. 9408–9421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Nakamura, H. Yamamoto, T. Yao et al., “Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade,” Human Pathology, vol. 36, no. 7, pp. 828–837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Qin, Z. Chen, Y. Ding, J. Hao, J. Hu, and F. Guo, “Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis,” Neoplasma, vol. 60, no. 5, pp. 486–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. J. A. Tercero, K. Labib, and J. F. X. Diffley, “DNA synthesis at individual replication forks requires the essential initiation factor Cdc45p,” The EMBO Journal, vol. 19, no. 9, pp. 2082–2093, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Zou and B. Stillman, “Formation of a preinitiation complex by S-phase cyclin CDK-dependent loading of Cdc45p onto chromatin,” Science, vol. 280, no. 5363, pp. 593–596, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Cheng, J. A. Vaisica, J. Ou et al., “Genome rearrangements caused by depletion of essential DNA replication proteins in Saccharomyces cerevisiae,” Genetics, vol. 192, no. 1, pp. 147–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. B. S. Lopez, P. Pasero, I. Magdalou, and S. A. E. Lambert, “The causes of replication stress and their consequences on genome stability and cell fate,” Seminars in Cell and Developmental Biology, vol. 30, pp. 154–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Demeyer and C. Van Nevel, “Methanogenesis, an integrated part of carbohydrate fermentation and its control,” in Digestion and Metabolism in the Ruminant, pp. 366–382, University of New England Publishing Unit, Armidale, Australia, 1975. View at Google Scholar
  54. S. M. Sivertsen, A. Bjørneklett, H. P. Gullestad, and K. Nygaard, “Breath methane and colorectal cancer,” Scandinavian Journal of Gastroenterology, vol. 27, no. 1, pp. 25–28, 1992. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Holma, R. Korpela, U. Sairanen et al., “Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer,” Journal of Clinical Gastroenterology, vol. 47, no. 1, pp. 45–51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Quan, R. G. Korneluk, M. B. Tropak, and R. A. Gravel, “Isolation and characterization of the human catalase gene,” Nucleic Acids Research, vol. 14, no. 13, pp. 5321–5335, 1986. View at Publisher · View at Google Scholar · View at Scopus
  57. D. G. Yoo, Y. J. Song, E. J. Cho et al., “Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems,” Lung Cancer, vol. 60, no. 2, pp. 277–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Sen, B. Kawahara, and G. Chaudhuri, “Maintenance of higher H2O2 levels, and its mechanism of action to induce growth in breast cancer cells: Important roles of bioactive catalase and PP2A,” Free Radical Biology and Medicine, vol. 53, no. 8, pp. 1541–1551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Manju, V. Balasubramanian, and N. Nalini, “Oxidative stress and tumor markers in cervical cancer patients,” Journal of Biochemistry, Molecular Biology and Biophysics, vol. 6, no. 6, pp. 387–390, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. S. H. Ko, S. H. Suh, B. J. Kim et al., “Expression of the intermediate filament vimentin in proliferatingduct cells as a marker of pancreatic precursor cells,” Pancreas, vol. 28, no. 2, pp. 121–128, 2004. View at Publisher · View at Google Scholar
  61. V. Carter, B. K. Shenton, B. Jaques et al., “Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation,” Transplantation Proceedings, vol. 37, no. 2, pp. 654–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Ivaska, H.-M. Pallari, J. Nevo, and J. E. Eriksson, “Novel functions of vimentin in cell adhesion, migration, and signaling,” Experimental Cell Research, vol. 313, no. 10, pp. 2050–2062, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Shirahata, M. Sakata, K. Sakuraba et al., “Vimentin methylation as a marker for advanced colorectal carcinoma,” Anticancer Research, vol. 29, no. 1, pp. 279–281, 2009. View at Google Scholar · View at Scopus
  64. V. L. Costa, R. Henrique, S. A. Danielsen et al., “Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples,” Clinical Cancer Research, vol. 16, no. 23, pp. 5842–5851, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Jung, L. Yi, J. Kim et al., “The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer,” Molecules and Cells, vol. 31, no. 5, pp. 405–411, 2011. View at Publisher · View at Google Scholar · View at Scopus